Private Capital Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-133
Closed 2218
2020
Q4
$0 Sell
133
-80
-38% -$170 ﹤0.01% 2166
2020
Q3
$0 Sell
213
-67
-24% -$191 ﹤0.01% 2159
2020
Q2
$1K Hold
280
﹤0.01% 1932
2020
Q1
$1K Buy
280
+61
+28% +$201 ﹤0.01% 1909
2019
Q4
$0 Buy
+219
New +$569 ﹤0.01% 2275

Other funds holding BMY.RT

Private Capital Group's BMY.RT Position: Q1 2021 in Review

Private Capital Group sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 133 shares.

Private Capital Group first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1K in Q2 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Private Capital Group reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Private Capital Group sold 133 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • Private Capital Group first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Private Capital Group's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Private Capital Group's 13F filing for Q1 2021, filed 12 Apr 2021.